XIE'S BRAND XP GOLDEN PILL Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

xie's brand xp golden pill

premier herbs sdn bhd - acacia catechu; bos taurus domesticus; buthus martensii; daemonorops draco; lonicera japonica; poria cocos; pteria martensii; scolopendra subspinipes mutilans; sophora japonica; ziziphus jujuba; nidus vespae -

ACACIA ARABICA GRANULE (2DH-30DH) TABLET Canada - English - Health Canada

acacia arabica granule (2dh-30dh) tablet

homeocan inc. - acacia - tablet - 2dh - acacia 2dh - homeopathic products

ACACIA ARABICA GLOBULES Canada - English - Health Canada

acacia arabica globules

homeocan inc. - acacia - globules - 2x - acacia 2x - homeopathic products

ROBINA PSEUDO ACACIA GRANULE 1DH - 30CH TABLET Canada - English - Health Canada

robina pseudo acacia granule 1dh - 30ch tablet

dolisos laboratoires s.a. - acacia - tablet - 1dh - acacia 1dh - homeopathic products

ROBINA PSEUDO ACACIA GOUTTE 4CH-30CH DROPS Canada - English - Health Canada

robina pseudo acacia goutte 4ch-30ch drops

dolisos laboratoires s.a. - acacia - drops - 1ch - acacia 1ch - homeopathic products

CENTER-AL - ACACIA LONGIFOLIA POLLEN- acacia longifolia pollen injection, suspension
CENTER-AL - ALNUS INCANA SSP. RUGOSA POLLE United States - English - NLM (National Library of Medicine)

center-al - acacia longifolia pollen- acacia longifolia pollen injection, suspension center-al - alnus incana ssp. rugosa polle

alk-abello, inc. - acacia longifolia pollen (unii: 24so2j296o) (acacia longifolia pollen - unii:24so2j296o) - acacia longifolia pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

ROBINIA PSEUDOACACIA- black locust granule United States - English - NLM (National Library of Medicine)

robinia pseudoacacia- black locust granule

seroyal usa - robinia pseudoacacia bark (unii: 7tpc058owy) (robinia pseudoacacia bark - unii:7tpc058owy) - robinia pseudoacacia bark 1 [hp_x] - indications helps to support a healthy digestive system indications helps to support a healthy digestive system directions adults: take five granules three times daily or as recommended by your healthcare practitioner. childern: take three granules and follow adult directions.

Allergenic Extract United States - English - NLM (National Library of Medicine)

allergenic extract

nelco laboratories, inc. - acacia baileyana pollen (unii: 59wav8g5x5) (acacia baileyana pollen - unii:59wav8g5x5) - acacia baileyana pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t